The cost of home care for patients with malignant neoplasms.
A microeconomic study evaluated the health sector cost of home care in Greece for patients with malignant neoplasms. A cost-identification analysis was performed from the home care service's perspective. According to the results of the study, the cost varies among the main categories of malignant neoplasms because of a fluctuation in the cost of drugs, whereas the main cost-driver factor is the cost of laboratory tests. In comparison with the corresponding cost of in-hospital care, the cost of home care for patients with malignant neoplasms is significantly lower, which also is confirmed by the results of other international studies.
Kouli
Eugenia
E
Nursing Department, University of Athens, Athens, Greece. eugeniakouli@yahoo.gr
Kaitelidou
Daphne
D
Kalokerinou-Anagnostopoulou
Athena
A
Siskou
Olga
O
D000368:Aged; D005260:Female; D006115:Greece; D019981:Health Care Sector / Q000706:statistics & numerical data; D018575:Home Care Services, Hospital-Based / Q000191:economics* / Q000706:statistics & numerical data / Q000639:trends; D006760:Hospitalization / Q000191:economics* / Q000706:statistics & numerical data; D006801:Humans; D008297:Male; D009369:Neoplasms / Q000145:classification / Q000191:economics* / Q000401:mortality